Indication
Anzupgo is indicated for the treatment of moderate to severe chronic hand eczema (CHE)
Loading your page…
Loading your page…
Dermatitis;Eczema
Marketing Authorisation Holder: LEO Pharma A/S
EMA Authorisation: 19/09/2024
INN: delgocitinib
AI Drug & Interaction Analysis
Free account required
Ask Osler about Anzupgo: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.